1. Home
  2. PBBK vs PULM Comparison

PBBK vs PULM Comparison

Compare PBBK & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBBK
  • PULM
  • Stock Information
  • Founded
  • PBBK 1919
  • PULM 2003
  • Country
  • PBBK United States
  • PULM United States
  • Employees
  • PBBK N/A
  • PULM N/A
  • Industry
  • PBBK Banks
  • PULM Biotechnology: Pharmaceutical Preparations
  • Sector
  • PBBK Finance
  • PULM Health Care
  • Exchange
  • PBBK Nasdaq
  • PULM Nasdaq
  • Market Cap
  • PBBK 35.6M
  • PULM 30.9M
  • IPO Year
  • PBBK N/A
  • PULM N/A
  • Fundamental
  • Price
  • PBBK $15.39
  • PULM $6.47
  • Analyst Decision
  • PBBK
  • PULM
  • Analyst Count
  • PBBK 0
  • PULM 0
  • Target Price
  • PBBK N/A
  • PULM N/A
  • AVG Volume (30 Days)
  • PBBK 2.7K
  • PULM 17.9K
  • Earning Date
  • PBBK 05-14-2025
  • PULM 05-09-2025
  • Dividend Yield
  • PBBK N/A
  • PULM N/A
  • EPS Growth
  • PBBK N/A
  • PULM N/A
  • EPS
  • PBBK 0.76
  • PULM N/A
  • Revenue
  • PBBK $12,444,000.00
  • PULM $7,806,000.00
  • Revenue This Year
  • PBBK N/A
  • PULM N/A
  • Revenue Next Year
  • PBBK N/A
  • PULM $134.88
  • P/E Ratio
  • PBBK $19.75
  • PULM N/A
  • Revenue Growth
  • PBBK 1.44
  • PULM 6.96
  • 52 Week Low
  • PBBK $12.10
  • PULM $1.72
  • 52 Week High
  • PBBK $17.75
  • PULM $10.40
  • Technical
  • Relative Strength Index (RSI)
  • PBBK 46.60
  • PULM 52.16
  • Support Level
  • PBBK $14.93
  • PULM $5.31
  • Resistance Level
  • PBBK $16.60
  • PULM $6.52
  • Average True Range (ATR)
  • PBBK 0.21
  • PULM 0.46
  • MACD
  • PBBK -0.03
  • PULM 0.14
  • Stochastic Oscillator
  • PBBK 65.17
  • PULM 83.01

About PBBK PB Bankshares Inc.

PB Bankshares Inc follows a community bank model and provides multiple services to individuals and small to midsize businesses. Its business consists of attracting retail and commercial deposits from the general public in its market area and investing those deposits, together with funds generated from operations and borrowings, in commercial real estate loans, commercial and industrial loans, construction, home equity lines of credit and to a lesser extent, one- to four-family residential real estate loans and consumer loans.

About PULM Pulmatrix Inc.

Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.

Share on Social Networks: